GTPC

General Terms and Conditions of Purchase (GTPC) for Cheplapharm Group Entities in Germany

 

SECTION I – Application 

 
Application / Definitions

(1.) The General Terms and Purchase Conditions. (GTPC) as updated from time to time shall form an integral part of all contracts concluded between Cheplapharm Arzneimittel GmbH or their Affiliates ("Cheplapharm") and their contractual partners ("Supplier") for the procurement of goods and/or services by means of a purchase order, statement of work, or similar document or communication, including, without limitation, through electronic ordering systems.

(2.) These GTPCs shall govern any contract between Cheplapharm and Supplier for 

(a) Supplier’s manufacturing and delivery of certain goods ("Products") and/or 

(b) Supplier’s performance of certain services including the provision of deliverables, as specified in the relevant contract ("Services"). 

(3.) This shall apply even if Cheplapharm does not refer to them in each individual case.

(4.) If the subject matter of the contract is both the manufacturing and/or delivery of Products and the performance of Services, all sections of these GTPC shall apply respectively. 

(5.) The GTPC shall apply exclusively and shall take precedence over any terms and conditions of Supplier even if Cheplapharm does not expressly object to such terms and conditions, accepts Supplier’s performance without reservation. 

 
Quality Assurance

(6.) If required by Applicable Standards or if requested by Cheplapharm, the Parties shall enter into a Quality Agreement, which shall be deemed incorporated into this contract.

Applicable Standards

(7.) Applicable Standards shall mean all applicable laws, regulations, rules, directives, statutes, orders, treaties, and other legal requirements including but not limited to, (a) all applicable current good manufacturing, guidelines (collectively, cGxP), (b) the HSE Requirements ("HSE Requirements" means all applicable laws, regulations and officially binding requirements relating to occupational health and safety, environmental protection, hazardous substances, waste management and accident prevention), (c) applicable good industry practices and industry standards. 

(8.) In the event of a conflict between these GTPC and/or any other agreement, made in parallel between the Parties (such as for example the Quality Agreement) and/or mandatory Applicable Standards and/or any applicable cGxP, Supplier those shall prevail. In all other matters, these GTPC shall prevail. 

SECTION II - Products

 
Supplier Product Warranty

(9.) Supplier shall manufacture and/or supply Products in accordance with the contract, including these GTPC, any applicable Quality Agreement and all Applicable Standards.

(10.) Supplier represents and warrants that it will manufacture, store, test release, deliver and/or supply Products in compliance with the agreed specifications; any applicable Quality Agreement; any applicable manufacturing license(s); any other procedures agreed upon by the parties; and/or all Applicable Standards, including, without limitation, the HSE Requirements defined in clause (7.).

Defective Products

(11.) Definitions:

"Defective Product" shall mean a Product that is not or has not been manufactured in conformity with the agreed requirements.

The term "Defect" shall be interpreted accordingly.  A Defect can be an apparent Defect or a Latent Defect.  

"Apparent Defect" means a defect that can be identified during a customary incoming inspection. 

"Latent Defect" means a defect that cannot reasonably be identified during a customary incoming inspection and is only discovered at a later stage.

"Shelf life" means the period between the date from which the Product's expiry date is calculated under Applicable Laws and the Product's expiry date.

(12.) Supplier warrants at delivery, the Products shall be free from Defects and have a remaining Shelf life of at least 90% upon delivery unless otherwise agreed in writing.

(13.) Product Warranty Period. Supplier’s warranty shall remain in full force and effect for at least the entire agreed residual shelf life of the Products, for 24 months after delivery of the Products, or for a period specified by Applicable Standards, whichever period is longer.

 
Cheplapharm´s Duty to inspect

(14.) Cheplapharm shall inspect and notify the Supplier regarding any Defects in accordance with Section 377 German Commercial Code (Handelsgesetzbuch, HGB). A general description of the defect shall be sufficient.

(15.) With respect to apparent Defects, notice shall be given within 12 Business days after arrival of Products at the place of delivery specified in the applicable Purchase Order and/or Master Supply Agreement. With respect to latent Defects, notice shall be given within 2 weeks after discovery of the Defect.  

(16.) Business days shall be Monday to Friday, excluding public holidays at Cheplapharm’s registered office and at the location designated by Cheplapharm for receipt of Products. 

(17.) The notice of Defect shall be made in writing (email to suffice) and it shall be sufficient if it claims the existence of the Defect. Cheplapharm shall have the right to submit additional documentation subsequently, without affecting its timeliness.

(18.) If Cheplapharm detects an apparent Defect during the incoming inspection, Cheplapharm shall have the right to reject the entire amount of Products delivered without regard to the reasonableness of separating the Products under such delivery. Partial acceptance of any Products delivered shall be at Cheplapharm’s sole discretion. 

(19.) Cheplapharm shall not be required to notify a Defect where the Supplier knew or ought reasonably to have known of such Defect at the time of delivery.

(20.) Any Defect which is detected during the Product Warranty Period shall be presumed to have been in existence at the time of delivery, unless Supplier can demonstrate that such presumption is incompatible with the nature of the Defect.

 
Remedies for Defective Products

(21.) If Products, are defective, Cheplapharm may require Supplier, at Cheplapharm´s discretion, to promptly repair or replace the Defective Products. All costs associated with such repair or replacement, including transportation, disposal costs, etc. shall be borne by Supplier. 

(22.) If Supplier fails to repair or replace the Defective Products within a reasonable period specified by Cheplapharm, taking into account the nature of the Defect and the operational requirements of Cheplapharm, or if repair or replacement is not feasible, Cheplapharm may reject the Defective Products, terminate or withdraw from the affected Order in whole or in part, and procure replacement products from a third party. Supplier shall reimburse Cheplapharm for the reasonable additional costs incurred as a result of such replacement procurement.

(23.) Supplier shall reimburse Cheplapharm for all reasonable additional costs incurred in connection with the Defective Products, including the reasonable costs of any replacement procurement pursuant to Clause (22.). 

(24.). Any further statutory or contractual rights and remedies of Cheplapharm, including claims for damages, shall remain unaffected.

(25.) Payment of Defective Products upon delivery shall not be deemed to imply any acceptance of such Products.

(26.) Without prejudice to Cheplapharm’ rights and remedies and aligned with Cheplapharms choice according to (21.) to (28.), Supplier shall promptly instruct Cheplapharm to either send any Defective Products (and, if applicable, Products from the same or related batch(es)), back to Supplier or dispose thereof, at Supplier’s discretion and expense.

(27.) If any shipment contains a Defective Product, Cheplapharm shall be entitled to reject the entire batch and also the shipment.

(28.) Cheplapharm’s rights and remedies for Defective Products under this section, clauses (21.) to (28.) shall be cumulative, and in addition to any other rights or remedies available to Cheplapharm , including, without limitation, Cheplapharm’s right to claim damages.

 
Delivery

(29.) Supplier shall deliver Products at the delivery date and time and in the quantity specified in the contract.

(30.) Supplier shall deliver Products to the precise address specified in the contract or as otherwise notified to Supplier from time to time. Unless agreed otherwise, Supplier shall deliver Products DDP (Delivered Duty Paid) under INCOTERMS 2020® to the place of delivery as specified in the contract.

(31.) Supplier shall notify Cheplapharm of all deliveries of Products in due course, at the latest 3 days prior to dispatch, by means of a (dispatch) notice detailing the type, quantity and, if applicable, the (net) weight. Supplier shall state the respective Cheplapharm order number and material number on all shipping and order documents and in related correspondence, in particular on dispatch notes, bills of lading and invoices.

(32.) Unless expressly authorized by Cheplapharm in writing, Supplier shall not be entitled to partial deliveries and/or invoicing of Products.

 
Delay | Failure in Supply

(33.) Supplier shall promptly notify Cheplapharm in writing (email to suffice) of any actual or anticipated delay in supply of Products in whole or in part stating the reason(s) for delay, mitigation steps and estimated effect on agreed timelines.

(34.) If Cheplapharm accepts a delayed delivery, this shall not constitute a waiver of any rights or remedies available to Cheplapharm.

(35.) If Supplier fails to deliver the Products on the agreed delivery date, Cheplapharm may claim a contractual penalty of 0.5% of the value of the delayed Products for each commenced week of delay, up to a maximum aggregate amount of 5% of the value of the delayed Products. The contractual penalty shall be payable in addition to Supplier's obligation to perform. Cheplapharm may assert the contractual penalty until final payment of the affected Order. Any contractual penalty paid by Supplier shall be credited against any claim for damages arising from the same delay. Cheplapharm shall remain entitled to claim damages exceeding the amount of the contractual penalty upon proof of such damages.

(36.) Cheplapharm shall be entitled to exercise its rights under this section "Delay| Failure in Supply" immediately without providing Supplier with prior written notice and/or granting Supplier a grace period.

(37.) Cheplapharm’s rights and remedies for delay or failure in supply of Products under this section shall be cumulative, and in addition to any other rights or remedies available to Cheplapharm..

 
Spare Parts | Last Time Buy

(38.) Supplier shall keep a reasonable supply of spare parts, consumables and/or other items that are required on a recurring basis for the use or operation of any Products (collectively "Spare Parts") for the period of the expected use or operation of such Products by Cheplapharm, however, for at least 10 years after the last shipment of such Product, and to supply such Spare Parts to Cheplapharm upon request in good faith on reasonable terms.

(39.) If Supplier ceases supply of certain Products during the period specified in Clause (38.) or ceases supply of Spare Parts upon expiry of such period, Supplier shall inform Cheplapharm thereof with reasonable prior notice and Cheplapharm shall have the one-time right to place a final order for such Products and/or Spare Parts in a reasonable amount which Supplier shall supply to Cheplapharm.

 
Ownership | Provision of Materials

(40.) Title to Products shall be transferred to Cheplapharm upon delivery unless otherwise agreed in writing between the Parties. Notwithstanding the foregoing, all Cheplapharm Materials and all Products manufactured from such materials shall remain or become the property of Cheplapharm at all times. Supplier shall be responsible for any loss, damage, destruction, contamination, misappropriation or unauthorized use of materials provided by or on behalf of Cheplapharm while such materials are in Supplier's possession or control, except to the extent caused by Cheplapharm.

(41.) To the extent that Cheplapharm and Supplier have agreed that Cheplapharm shall provide materials or other items for the performance of the contract, Supplier must not use such materials or items for any other purposes than the performance of its obligations under the contract. Any materials, components, tooling, packaging materials, specifications, documents or other items provided by or on behalf of Cheplapharm shall remain the sole property of Cheplapharm unless otherwise agreed in writing. Supplier shall clearly identify, segregate, protect and use such items exclusively for the performance of the applicable contract.

(42.) To the extent Supplier processes, transforms, combines or commingles materials owned by Cheplapharm, such activities shall be performed on Cheplapharm's behalf. To the fullest extent permitted by applicable law, Cheplapharm shall acquire ownership of the resulting products, intermediate products and work-in-process. 

 
Inspection of Materials and Components 

(43.) Supplier shall perform a thorough incoming inspection of all raw materials used in the manufacture of Products.

 
Labeling | Product Information

(44.) Supplier shall ensure that all Products will be labeled in accordance with Applicable Standards.

(45.) Supplier shall ensure that all Products will be accompanied by all documents (including delivery bills) required in accordance with Applicable Standards.

 
Packaging

(46.) All Products shall be transported and delivered packaged in accordance with Applicable Standards unless agreed otherwise.

(47.) Supplier shall ensure that the packaging of Products, including (as applicable) any packaging for transportation, will fully comply with the requirements set forth in the contract including these GTPC, the Quality Agreement and/or Applicable Standards.

(48.) If Products are handed over or delivered in damaged or dirty/contaminated packaging, Cheplapharm (or its designated carrier) shall be entitled to reject the shipment in its entirety without inspecting the contents. Supplier shall bear the costs of any return shipment. In addition, Clause (33.) to (37.) shall apply.

(49.) Upon delivery of Products, packaging materials shall become Cheplapharm’s property. 

 
Registration | HSE | REACH Requirements

(50.) Supplier shall (and shall cause its subcontractors and Suppliers to) provide all information, documentation, and assistance required for the Product registration with competent regulatory authorities.

(51.) Supplier shall (and shall cause its subcontractors and Suppliers to) comply with HSE Requirements.

(52.) Supplier shall maintain an HSE audit due diligence and assessment program for its supply chain, failure of which shall constitute a material breach of the contract and shall entitle Cheplapharm to terminate the contract in accordance with Clause (106.) to (110.) "Term and Termination".

Product Recalls

(53.) Upon discovery that a Product that is a pharmaceutical products in finished dosage form (FDF) or bulk form should be recalled or corrected, or may be required to be recalled or corrected, the discovering party shall promptly notify the quality assurance contact of the other party.

In case of a product recall contact Cheplapharm:

qa-recall@cheplapharm.com

The decision to initiate a recall or to take other corrective action shall be made and implemented by Cheplapharm in its sole discretion. 

(54.) In the event of a recall, Supplier shall, at Cheplapharm’s request, replace the recalled Products, regardless of whether or not such Products are Defective, with new Products in accordance with Clauses (21.) to (28.). 

SECTION III - Services

 
Supplier Services Warranty

(55.) Supplier shall perform Services in accordance with the contract including these GTPC, the Quality Agreement other and Applicable Standards.

(56.) Supplier represents and warrants that: 

(a) Services will be performed (i) in accordance with the agreed specifications and any applicable Quality Agreement; (ii) in compliance with all Applicable Standards, all Cheplapharm instructions, policies and procedures applicable to such Services or to Supplier and any other procedures agreed between the parties; and (iii) in a timely and professional manner with a high degree of care and skill consistent with applicable industry standards and practices; 

(b) Services and Results will not (i) infringe any third party rights, including, without limitation, intellectual property rights; (ii) contain elements affecting their use by Cheplapharm under the contract including these GTPC; (iii) cause Cheplapharm or its Affiliates to breach any laws, regulations, codes or industry guidelines in a manner adversely affecting their reputation; or (iv) involve any actual or perceived conflict of interest adversely affecting Supplier’s contractual obligations under the contract including these GTPC. 

(c) Manufacturing and supply of Products shall always be governed by Section II irrespective of any characterization as services.

Defective Services

(57.) Defective Service shall mean a Service that was not performed in compliance with the Supplier Service Warranty set forth in Section III (Services). The term Defect shall be interpreted accordingly.

 
Remedies for Defective Services

(58.) To the extent that the Services are Defective, Cheplapharm may, at its option:

(a) require Supplier to promptly re-perform or remedy the Defective Services at Supplier's cost and expense;

(b) if Supplier fails to remedy or re-perform the Defective Services within fifteen (15) Business Days after receipt of notice from Cheplapharm, or if such remedy or re-performance is not feasible, terminate or withdraw from the affected contract in whole or in part;

(c) obtain equivalent services from a third party and recover from Supplier the reasonable additional costs incurred by Cheplapharm to the extent such third-party services exceed the fees that would have been payable to Supplier for the affected Services; and/or

(d) recover from Supplier any direct losses, costs, expenses, fees, penalties or damages reasonably incurred by Cheplapharm as a result of the Defective Services, in each case to the extent permitted by applicable law.

(59.) Payment for Services shall not constitute acceptance of such Services nor a waiver of any rights or remedies available to Cheplapharm.

(60.) The rights and remedies set out in this Clause are cumulative and are in addition to any rights or remedies available at law or under the Agreement.

 
Acceptance of Services

(61.) Cheplapharm’s acceptance shall only be given expressly and shall not be deemed given even if Cheplapharm uses or pays for the relevant Services prior to formal acceptance.

(62.) Upon completion of the Services, Supplier shall notify Buyer in writing that the Services are ready for acceptance and shall provide all documentation reasonably required for the acceptance. 

(63.) Cheplapharm shall be entitled to inspect and test the Services within twenty (20) Business Days after receipt of Supplier's notice of completion. Where the nature, scope or complexity of the Services reasonably requires additional time, such inspection period shall be extended accordingly.

(64.) Cheplapharm shall either accept the Services or notify Supplier of any material non-conformities identified during such inspection period. Acceptance shall occur only upon Buyer's written confirmation. Use of the Services shall not constitute acceptance. Supplier shall bear any costs of acceptance.

 
Services Failure | Delay

(65.) Supplier shall promptly notify Cheplapharm in writing (email to suffice) of any actual or anticipated delay in performance of Services in whole or in part stating the reason(s) for delay, potential mitigation steps and estimated effect on the timelines.

 (66.) In the event of an actual or anticipated delay in performance of Services in whole or in part, Cheplapharm shall be entitled to, at its sole discretion and direction: 

(a) withdraw from or terminate the contract in whole or in part without any penalty to Cheplapharm; 

(b)recover from Supplier any direct losses, costs, expenses, fees, penalties or damages reasonably incurred by Cheplapharm as a result of the delayed Services, in each case to the extent permitted by applicable law.

(67.) Cheplapharm shall be entitled to exercise its rights under the Clauses (65.) to (69.) immediately without providing Supplier with prior written notice and/or granting Supplier a grace period, unless mandatory Applicable Law requires otherwise.

(68.) If Supplier fails to perform, materially underperforms, or otherwise performs any Services in a manner that does not comply with this Agreement, Supplier shall, without prejudice to any other rights or remedies available to Cheplapharm, and at Cheplapharm’s sole discretion, promptly refund or credit all amounts paid by Cheplapharm for the affected Services.

For the avoidance of doubt, such refund or credit shall not constitute Cheplapharm’s exclusive remedy. Cheplapharm shall remain entitled to claim damages, indemnification, reimbursement of costs and expenses, or any other remedy available under this Agreement or applicable law in respect of any loss, damage, cost, expense or liability arising from or in connection with such non-performance, deficient performance or non-compliance.

(69.) Cheplapharm’s rights and remedies for delay or failure in performance of Services under Clauses (65.) to (69.) shall be cumulative, and in addition to any other rights or remedies available to Cheplapharm.

 
Transport and Logistics

(70.) For Services involving transport and logistics, the additional provisions of this section "Transport and Logistics Services"  shall apply.

(71.) Supplier providing transport or logistics Services shall comply with all Applicable Standards and all national and international transport regulations applicable to the Services, including, where relevant, ADR, CMR, Montreal Convention, Hague-Visby Rules and comparable regulations, each as amended from time to time, including, without limitation, applicable national and international conventions, such as the Allgemeine Deutsche Spediteurbedingungen (ADSp 2017), European Agreement concerning the International Carriage of Dangerous Goods by Road (ADR), the international Convention relative au contrat de transport international de marchandises par route (CMR), the 1929 Warsaw Convention or the 1999 Montreal Convention, and/or the Hague Visby Rules, each as amended from time to time. 

(72.) Supplier shall ensure that all transport documents required under Applicable Standards are complete, accurate and available during transport.

(73.) Supplier shall especially ensure, that the relevant ADR transport document (i.e. the dangerous goods shipping note) as well as any documentation (subject to the provisions of the contract including these GTPC) purporting the trail or detailing the movement of the goods, including, without limitation, the CMR Transport Document, bill of lading, air waybill and the collection notes (Transport Document) will be complete and on board the respective vehicles.

(74.) Supplier shall not exercise and shall ensure that its subcontractors do not exercise any lien, pledge or retention right over Cheplapharm goods.

(75.) Supplier shall transport goods safely, timely and under the temperature conditions specified by Cheplapharm.

(76.) Supplier shall implement procedures ensuring inspection and documentation of visible damage and temperature deviations at key transport handover points.

(77.) Where Supplier acts as carrier, freight forwarder or logistics provider it shall issue or procure all transport documents required by Applicable Standards.

(78.) Supplier shall remain liable to the maximum extent permitted under the applicable transport convention and Applicable Standards.

SECTION IV - General Provisions

 
Delivery and Service Timelines

(79.) Any items or activities which can be reasonably expected to be required for delivery of Products and/or rendering of Services shall be deemed to be included in such Products and/or Services.

(80.) Premature delivery of Products or performance of Services by Supplier shall only be permitted with Cheplapharm’s prior written approval.

Subcontracting

(81.) Supplier must not subcontract any obligations under the contract to any third party without Cheplapharm’s prior written approval and validation. 

 
Registration, Licenses and Permits

(82.) Supplier represents and warrants that throughout the term of the contract, Supplier and/or its subcontractors will have obtained and will maintain in good standing any and all registrations, licenses and permits required to provide the Products and/or Services. 

(83.) Upon request, Supplier shall provide, or shall cause its subcontractors to provide, to Cheplapharm copies of such registrations, licenses and permits.

(84.) Without prejudice to any of Cheplapharm’s other rights under the contract including these GTPC, Supplier shall inform Cheplapharm promptly in writing of any actual or threatened denial, revocation, withdrawal or suspension of such registrations, licenses and permits.

(85.) Supplier shall immediately notify Cheplapharm in writing if any registration, licence, permit, authorisation or approval required for the performance of the Agreement is denied, revoked, withdrawn, suspended, restricted, expires without renewal or is otherwise jeopardised. 

Pharmacovigilance Assurance

(86.) If required by Applicable Standards or if requested by Cheplapharm, the Parties shall enter into a Pharmacovigilance Agreement .

 
Expenses | Travel Costs

(87.) Cheplapharm will not reimburse or separately pay for any disbursements or expenses incurred during delivery of Products and/or performance of Services (e.g. travel time, travel costs, accommodation, subsistence, third party charges), unless agreed otherwise. 

 
Purchase price | Fees

(88.) After complete delivery of goods and performance of services and upon receipt of an applicable and correct invoice, Cheplapharm shall pay to Supplier the purchase price and/or fee agreed in the contract.

 
Payment 

(89.) The Supplier shall submit electronic invoices to Cheplapharm upon shipment of the Product to the destination(s) set forth in the applicable Product Schedule. Cheplapharm shall pay all undisputed amounts due in EUR within 60 calendar days from the date of the invoice. Payment by the Cheplapharm does not constitute a waiver of any of its rights under this Agreement. The Cheplapharm may offset any amount the Supplier owes the Cheplapharm against amounts payable under this or any other Agreement. Payments made within 15 days from the due date may be made at a discount of 2 % of the amount invoiced.

Invoices and credit notes must be sent exclusively by email to invoice-de@cheplapharm.com (one file per email; accepted formats: PDF, ZUGFeRD, or XRechnung including all attachments and required information). Postal submission is not required.

Dunning notices and other accounts payable correspondence should be sent to finance@cheplapharm.com.

Incorrect invoices (e.g., missing order number or incorrect recipient) will not be processed. In case an erroneous invoice is detected, Cheplapharm will give Supplier notice about the mistake and request a corrected invoice. 

 
Withholding of Payments

(90.) Cheplapharm shall pay the undisputed portion of an invoice duly delivered in accordance with the contract and shall be entitled to withhold payment on any disputed portion of an invoice until such dispute is resolved.

(91.) Without prejudice to Cheplapharm’s other rights and remedies, Cheplapharm shall be entitled to withhold the relevant payments until complete delivery of Products or performance of Services as agreed.

 
Taxes

(92.) Unless expressly agreed otherwise, all prices, fees and other amounts payable under the Agreement are exclusive of value added tax (VAT) but inclusive of all other taxes, duties, levies, charges, social contributions and similar governmental assessments imposed on Supplier in connection with the performance of the Agreement.

(93.) Supplier shall be solely responsible for the payment of all taxes, duties, contributions and other charges imposed on Supplier, its personnel or subcontractors in connection with its performance under the Agreement.

(94.) Where VAT is properly chargeable under applicable law, Supplier shall separately state such VAT on its invoice. All invoices shall comply with the applicable requirements of German VAT law and any other applicable tax laws. Cheplapharm shall not be obliged to pay VAT shown on an invoice that does not comply with such requirements.

(95.) To the extent that any payment under the Agreement is subject to withholding tax or any other mandatory tax deduction under applicable law, Cheplapharm shall be entitled to deduct and withhold such tax from the relevant payment and remit it to the competent tax authority. Any such deduction or withholding shall be deemed a payment to Supplier for all purposes of the Agreement.

(96.) Supplier shall, upon request and without undue delay, provide Cheplapharm with all documents, certificates, forms and information reasonably required to obtain any exemption, reduction, refund or credit of withholding taxes under applicable law or any applicable double taxation treaty. Supplier shall bear any adverse tax consequences resulting from its failure to provide such documentation in a timely manner.

(97.) Unless expressly agreed otherwise in writing, Cheplapharm shall have no obligation to gross up any payment for withholding taxes, duties or similar charges.

(98.) If a tax authority challenges the VAT treatment, withholding tax treatment or any other tax treatment applied by Supplier and such challenge results from Supplier’s act, omission, incorrect invoicing, incorrect classification or breach of applicable tax laws, Supplier shall indemnify and hold harmless Cheplapharm from and against any resulting taxes, interest, penalties, costs and expenses.

(99.) Where a reverse-charge mechanism applies under applicable law, Supplier shall issue its invoice accordingly and shall not charge VAT. The Parties shall reasonably cooperate to ensure the correct tax treatment of the relevant transaction.

 
No Suspension

(100.) Unless provided for by mandatory Applicable Standards, Supplier shall not be entitled to suspend delivery of Products and/or performance of Services.

 
Limited Set-off and Retention

(101.) Supplier shall only be entitled to set off any claims by Cheplapharm against Supplier’s undisputed or finally established claims which are based on the same contract as the claim asserted by Cheplapharm.

(102.) Cheplapharm shall be free to set off any claims and to exercise any right of retention in accordance with Applicable Standards. 

 
Time Limitation of Supplier´s Claim 

(103.) Supplier’s Claims Supplier’s claims against Cheplapharm shall expire 

(a) 24 months after the date on which the cause of action arises, or, 

(b) in accordance with Applicable Standards, whichever period is shorter. The foregoing shall not apply to claims arising from Cheplapharm’s willful misconduct, which shall expire in accordance with Applicable Standards.

 
No Waiver

(104.) The unconditional receipt or acceptance or payment of Products and/or Services by Cheplapharm shall not constitute a waiver of Cheplapharm with regard to its rights and remedies under the contract including these GTPC and/or Applicable Standards for delays in the delivery or Defective Products and/or Services.

 
Intellectual Property 

(105.) Neither Party shall, as a result of this contract, acquire any right, title, or interest in any intellectual property that the other Party owns or controls as of the Effective Date, or that the other Party obtains ownership or control of separately and apart from the performance of this Agreement.

The Supplier hereby grants to the Cheplapharm an exclusive, worldwide, fully paid-up, irrevocable, perpetual and transferable licence, with the right to grant and authorise sublicences, to use all Toll Supplier's intellectual property with regard to the Product and, to the extent necessary to develop, manufacture, market, commercialise, make, use, sell, import, and distribute the Product.

 
Term and Termination

(106.) The contract shall become effective on the date specified therein or, at the latest, upon Supplier’s performance under the contract and shall remain in force until the date specified therein, unless terminated earlier in accordance with this section "Term and Termination".

(107.) Cheplapharm shall be entitled to terminate any contract for Services for convenience in whole or in part at any time at its sole discretion upon 30 days’ notice to Supplier. Supplier shall not be entitled to terminate any contract for Services for convenience. Cheplapharm may terminate the Agreement with immediate effect by written notice if any registration, licence, permit, authorisation or approval required for Supplier's performance of the Agreement is denied, revoked, withdrawn, suspended, materially restricted or expires without renewal.

(108.) Each party shall be entitled to terminate the contract for material breach, provided that such breach remains uncured for 30 days following receipt of written notice (email to suffice) from the other party specifying the breach. Such notice shall not be required if 

(a) the material breach is not curable; and/or 

(b) if the other party cannot reasonably be expected to continue the contract until expiry of such period.

(109.) Upon expiration or termination of any contract for Services, the parties shall cooperate to discontinue such Services in the most cost-effective manner possible. Supplier shall work, assist and provide necessary document/information to Cheplapharm and to any appointed third-party Supplier as Cheplapharm may request, in such a manner as is required to ensure an orderly transfer of the Services, and to prevent or mitigate any inconvenience or disruption to Cheplapharm or its business.

(110.) Any termination notice shall be given in writing (email to suffice).

 
Indemnification from Third-Party Claims

(111.) Supplier shall indemnify, defend and hold Cheplapharm and its Affiliates (including, without limitation, their respective officers, directors, employees, contractors and agents) harmless from and against any third party claims, demands, causes of action, damages, liabilities, losses, costs and expenses (including, without limitation, reasonable attorneys’ and experts’ fees), penalties, and compensatory, multiple, exemplary, and punitive damages (collectively, Third-Party Claims), arising out of, or resulting from 

(a) the breach by Supplier of any of its warranties, representations or obligations under the contract including these GTPC; 

(b) failure of Supplier to comply with Applicable Standards; or (c) any assertion that the Products and/or Services infringe or misappropriate any intellectual property right of any third party except to the extent such claim arises from specifications, designs, formulations, instructions or materials provided by Cheplapharm.

 Liability

(112.) Supplier shall be liable for all damages, losses, costs and expenses suffered by Cheplapharm due to Supplier´s breach of its obligations under the contract

(113.) Without prejudice to Clause (115.), Cheplapharm shall not be liable for any indirect, consequential, special, punitive or incidental damages, including, without limitation, for loss of profits, loss of business, loss of business opportunity, loss of reputation or goodwill, revenue, data, or use, or any other consequential loss, under any statute or otherwise, whether in contract or tort.

(114.) Subject to Clauses (113.) and (115.), Cheplapharm’s aggregate liability for any damages and in respect of all claims and liabilities arising under the contract shall be limited to the amount of the purchase price and/or fees paid or payable by Cheplapharm under the contract in the 12-month period before the event that gave rise to the liability.

(115.) Nothing in the contract shall limit the parties’ liability for: 

(a) death or personal injury; 

(b) fraud or fraudulent misrepresentation; 

(c) gross negligence, willful default or willful misconduct; 

(d) the breach of essential contractual obligations, i.e. such obligations whose fulfillment is essential for the proper execution of the contract and on the compliance of which the other party regularly relies and may rely (cardinal obligations); 

(e) fraudulently concealed Defects; 

(f) claims under the Product Liability Act; and 

(g) in the event that a party expressly assumes a guarantee of quality; or 

(h) matters for which liability cannot be lawfully limited.

Force Majeure

(116.) Neither Party shall be liable for any delay or failure in the performance of its obligations under the Contract to the extent and for so long as such delay or failure results directly from a Force Majeure Event.

“Force Majeure Event” means unforeseeable events, beyond the reasonable control of (and thus not caused by) the Party which is thereby prevented from performing its obligation and which could not have been avoided even by the utmost care that can reasonably be expected, including acts of God, war, civil commotion, epidemics, quarantines or the destruction of production facilities or materials by fire, flood, earthquake, explosion or storm. Raw Material price increases, unavailability of Raw Materials, and labour disputes shall not be deemed an event of Force Majeure. 

In the event of Force Majeure, the Party prevented from or delayed in performing shall promptly give notice to the other Party. 

If either Party is unable to perform any of its obligations under this Agreement because of Force Majeure, the performance of such obligations shall be suspended to the extent and for the period required by such cause. 

In the event of Force Majeure, the affected Party shall use its best efforts, consistent with good business judgment, to eliminate, cure and overcome any of such causes and resume due performance of its obligations. 

Either Party may terminate this Agreement with immediate effect by giving notice to the other Party where the situation of Force Majeure continues for more than 3 months. In this case, the obligations that had been suspended due to Force Majeure, shall lapse accordingly.

Insurance

(117.) Except as otherwise specified, Supplier shall maintain appropriate and adequate insurance with a reputable and financially stable third-party insurance company(ies) to cover its liability under the contract, for the duration of the contract.

(118.) Upon Cheplapharm’s request, Supplier shall provide evidence of its insurance, especially of its third-party liability insurance.

 
Confidentiality

(119.) Confidential Information shall mean any information directly or indirectly disclosed or made accessible to Supplier by or on Cheplapharm’s behalf in connection with the contract, which is identified as ‘confidential’ or ‘proprietary’ or which, given its nature or the circumstances surrounding its disclosure, should reasonably be understood to be confidential or proprietary. Confidential Information includes, but shall not be limited to, technical, financial, economic, legal or tax information, personal data, trade and business secrets, know-how, procedures, developments, measurements, drawings, plans, as well as Results and the existence and content of the contract. Confidential Information does not include information that Supplier can demonstrate 

(a) it rightfully knew or possessed prior to receipt from Cheplapharm; 

(b) becomes public through no fault of Supplier; 

(c) is received by Supplier from a third party with the legal right to disclose it; or 

(d) has been independently developed by Supplier without utilizing Cheplapharm’s Confidential Information. 

(120.) Supplier shall use Confidential Information solely to exercise its rights and fulfill its obligations under the contract. Supplier shall take reasonable measures to avoid unauthorized disclosure or misuse of Confidential Information, including, without limitation, implementing security precautions at least as stringent as those it uses to protect its own Confidential Information. Supplier must not disclose Confidential Information without Cheplapharm’s prior written approval, except 

(a) to its Personnel and/or professional advisors who have a legitimate need to know Confidential Information, are informed of its confidential nature, and are bound by obligations of confidentiality and non-use no less restrictive than those contained herein; or 

(b) to the extent required by Applicable Standards, or judicial, governmental or regulatory order (provided that Supplier shall use reasonable efforts to notify Cheplapharm, unless legally prohibited, prior to disclosure to afford Cheplapharm the opportunity to, at its own cost and expense, seek a protective order or otherwise prevent or limit the disclosure). Supplier shall be responsible for any breach of this section "Confidentiality" and its clauses (119.) to (123.) by its Personnel and/or professional advisors.

Ownership of Confidential Information shall remain exclusively with Cheplapharm or its respective owner. No provision of the contract including these GTPC shall be construed to be a transfer of rights, title or interest or as a grant of a license with regard to Confidential Information. Cheplapharm does not warrant that Confidential Information provided to Supplier is complete, accurate, or usable by Supplier.

(121.) Upon termination or expiry of the contract or at any time upon Cheplapharm’s request, Supplier shall promptly return to Cheplapharm or demonstrably destroy all Confidential Information and any material that either contains or allows inferences to be drawn about Confidential Information and confirm to Cheplapharm in writing any such return or destruction.

(122.) Supplier must not disclose to Cheplapharm, nor include in any work product, any information of third parties that Supplier does not have the right to disclose or that Cheplapharm is not free to use without liability or other obligation.

(123.) The obligations under this section "Confidentiality" and its clauses (119.) to (123.)  shall survive the term of the contract for a period of 7 years.

 
Assignment of Contract

(124.) The contract shall not be assignable without the prior written approval of the other party. 

(125.) Notwithstanding the foregoing, Cheplapharm shall have the right, at its sole discretion, without Supplier’s consent, to assign the contract and/or any rights and obligations pertaining thereto to any of its Affiliates.

 
Access to Cheplapharm Premises

(126.) While on Cheplapharm’s premises, Supplier’s Personnel shall comply with any applicable site rules and safety regulations as well as any instructions given in relation to these by Cheplapharm. Supplier’s Personnel shall wear identification badges in plain sight at all times. 

(127.) Supplier shall promptly report any missing identification badges or access cards to Cheplapharm, and Supplier shall return all identification badges and access cards to Cheplapharm upon completion of any Services or upon Cheplapharm’s request. 

(128.) Cheplapharm reserves the right to deny access to or remove from its premises any individual who does not comply with Cheplapharm’s instructions, rules, regulations and policies.

SECTION V - Compliance

 
Sanctions

(129.) Each Party hereby represents and warrants that neither it, nor its knowledge any director, officer, agent or other Person acting on its behalf of is a Sanctioned Person or has any business affiliation or commercial dealings with a Sanctioned Person.

Each Party may refuse to fulfil its obligations under this Agreement insofar as the fulfilment is prohibited or impaired by applicable Sanctions or Export Control Laws. The reason for such refusal shall be communicated to the other Party in writing without undue delay. Each Party may terminate the Agreement insofar as the fulfilment of any of the obligations under this Agreement infringes applicable Sanctions or Export Control Laws. If only a part of the obligation is affected each Party may terminate the entire Agreement if the respective Party has no interest in partial performance. Claims for damages by the respective other Party are excluded insofar as the restrictions have not been negligently caused by the Party refusing to fulfil its obligations. 

For the purposes of this Clause (129.) the following definitions apply: "Sanctioned Person" means a person that is listed on, or owned or controlled by, or acting on behalf of, a person listed on any Sanctions List. "Sanctions List" means the European Union Consolidated Financial Sanctions List maintained by the European Commission, the Specially Designated Nationals and Blocked Persons list maintained by the Office of Foreign Assets Control of the US Department of Treasury (OFAC), or any other list issued or maintained by any Sanctions Authorities of persons subject to Sanctions (including investment or related restrictions), each as amended, supplemented or substituted from time to time. "Sanctions" means any applicable laws or regulations relating to economic or financial sanctions or trade embargoes or related restrictive measures imposed, administered or enforced from time to time by a Sanctions Authority. "Sanctions Authority" means (i) the United Nations Security Council; (ii) the European Union, (iii) the Member States of the European Union; (iv) the United States government; (v) the respective governmental institutions and agencies of any of the foregoing; and (vi) any other governmental institution or agency with responsibility for imposing, administering or enforcing Sanctions with jurisdiction over the Toll Supplier. "Export Control Laws" means any national and international foreign trade and customs requirements or restrictions including but not limited to those stipulated and enforced by the European Union, the Member States of the European Union and the United States of America.

Notification of Organizational Changes

(130.) Supplier warrants and represents that the information provided in KYC sheet is accurate and complete.

(131.) Supplier shall promptly inform Cheplapharm in writing of: (a) any material change to the information provided with any KYC questionnaire; and (b) of any change of Control of Supplier or person who Controls Supplier or if there is a change to the membership of Supplier’s executive body.

 
Records Retention

(132.) Supplier shall keep and maintain complete, appropriate and accurate Records related to the delivery of Products and/or performance of Services in accordance with Applicable Standards and relevant accounting practices and the Records Retention Period. 

(133.) Records shall be retained during the term of the contract and for the Records Retention Period.

(134.) Without limiting Supplier’s information security obligations under the contract, Supplier shall, at its sole cost and expense, maintain all Records in secure suitable facilities accessible to Cheplapharm during the Records Retention Period.

(135.) Record(s) shall mean all data, information, text, drawings, books, records (including, without limitation, financial and training records), expense reports, documents or materials recorded in any form (including, without limitation, those created by Supplier’s Personnel) relating to or connected with the contract including these GTPC and/or Supplier’s performance (including payment obligations). Records shall not include any materials that are subject to legal privilege.

(136.) Records Retention Period shall mean the period for which each of the Records shall be maintained, i.e. until the date which is the latest of 

(a) the earliest date specified by Applicable Standards/regulations/accounting standards; 

(b) the date of contract expiry/termination plus 10 years; 

(c) the date that the parties agree that all matters arising from or in connection with the contract including these GTPC or that Record have been finally concluded; or 

(d) the date as of which Record storage is no longer required under Cheplapharm's retention policy as notified to Supplier from time to time.

(137.) Relevant Payment(s) shall mean all payments made (a) by Cheplapharm to Supplier; or (b) made by Supplier, either for and on Cheplapharm’s behalf, or on its own account, and in each case, directly relating to Supplier’s obligations under the contract including these GTPC.

 
Audits Regulation

(138.) For the purpose of ensuring Supplier’s compliance with the contract and/or to confirm all Relevant Payments, Cheplapharm (and/or its appointed auditor) and regulatory authorities shall have the right, at any time upon reasonable prior notice from Cheplapharm, during the term of the contract and at least for 1 year thereafter to audit and have access to (i) all Records; (ii) Supplier’s compliance/anti-corruption program; (iii) any and all premises/facilities, networks, data processing and/or records retrieval systems owned, used or controlled by Supplier relating to or connected with the contract including these GTPC; (iv) information security measures implemented by Supplier; and (v) any other information that Cheplapharm and/or its appointed auditor reasonably considers necessary for the proper performance of their auditing duties.

(139.) The audit and access rights referenced under this section "Audits Regulation" shall include, without limitation, the right to (i) conduct face to face and/or on-line interviews with Supplier Personnel; (ii) access and review (in both soft and hard copy) any and all internal polices, internal audit reports, SOPs, procedures, guidelines, and/or other internal documentation of Supplier (including, without limitation, documentation with third parties relating to the audit scope and Supplier’s corporate structure); and (iii) review respective evidence and proof and all written explanations provided by Supplier to confirm its compliance with the contract including these GTPC and Relevant Payments.

(140.) Any audit (and related data collection activities) shall be carried out in compliance with Applicable Standards. Supplier shall provide reasonable and prompt cooperation in any audit.

(141.) To the extent that Supplier demonstrates that access to certain areas of its facilities and/or premises would cause a breach of its confidentiality undertakings to its other Cheplapharms, Supplier shall (instead of providing access to such certain areas) put in place reasonable workarounds to enable Cheplapharm to have access to resources and information reasonably required in order to carry out the audit. In respect of Records, Supplier must not refuse to provide access to a Record based on its confidentiality status.

(142.) Cheplapharm shall be entitled to appoint an auditor to perform any audit under the contract, and such auditor shall be subject to appropriate confidentiality obligations in relation to Supplier’s confidential information. Upon Cheplapharm’s written notice (email to suffice) that it wishes to conduct an audit, Supplier shall promptly comply with the requirements of this section "Audits Regulation".

(143.) Each party shall bear its own costs and expenses of any audit conducted under the contract provided that, in the event that an audit reveals an overcharge by Supplier of the purchase price and/or fees equal to or in excess of 5% of the total purchase price and/or fees incurred by Cheplapharm under the contract for the period in scope of the audit, Supplier shall bear the cost of the audit in full.

(144.) The audit and access rights referenced under this section "Audits Regulation" shall apply to Supplier and Supplier shall ensure to extend such rights to its Personnel, Affiliates, and Suppliers.

(145.) Supplier’s refusal or obstruction of Cheplapharm’s audit rights under this section shall constitute a material breach of the contract and shall entitle Cheplapharm to terminate the contract in accordance with Clauses (106.) to (110.) "Term and Termination" without compensation.

(146.) Supplier shall not be entitled to audit Cheplapharm in any way beyond Supplier’s audit rights under mandatory Applicable Standards. This applies to subjects and locations of audits as well as to methods and frequency of audits. Without prejudice to the foregoing, Cheplapharm will only accept audits upon appropriate prior written notice not to be less than 6 weeks.

 
Data Protection

(147.) To the extent that the parties’ performance under the contract includes the Processing of Personal Data as separate controllers, each party shall be separately and independently responsible for ensuring that its Processing is carried out in accordance with applicable Data Protection Laws. To the extent that Cheplapharm and Supplier jointly determine the purposes and means of Processing Personal Data, the parties shall enter into an appropriate arrangement defining their respective responsibilities for compliance with applicable Data Protection Laws, including, where applicable, an arrangement pursuant to Article 26 GDPR.

(148.) To the extent that Supplier’s performance under the contract includes the Processing of Personal Data by Supplier on behalf of Cheplapharm and under Cheplapharm’s instructions, the terms and conditions of the Cheplapharm Personal Data Protection Agreement, in the version applicable at the time of conclusion of the relevant contract, which can be viewed and downloaded from the corporate website under  https://www.cheplapharm.com, being  amended from time to time, shall apply in addition to these GTPC. 

(149.) Any transfer of Personal Data to a third country or international organisation shall comply with the applicable Data Protection Laws. Where required under applicable Data Protection Laws and no applicable adequacy decision exists, the parties shall implement an appropriate transfer mechanism, including, where applicable, the Standard Contractual Clauses adopted by the European Commission pursuant to Article 46(2)(c) GDPR or any other legally recognised transfer mechanism applicable to the relevant transfer. 

(150.) For the purpose of these GTPC, the expression Data Protection Laws shall mean any laws, regulations and orders of any jurisdiction relating to the privacy, security, confidentiality and/or integrity of Personal Data applicable to the Processing of Personal Data under the contract, including but not limited to the EU General Data Protection Regulation (2016/679); Processing and Personal Data shall have the meaning given to them in the applicable Data Protection Laws. Except as stated otherwise, the definitions above shall apply to all data protection related provisions in the contract including these GTPC or documents attached thereto.

SECTION VI - Final Provisions

 
Entire Agreement

(151.) The contract including these GTPC represents the entire agreement and understanding between the parties relating to the subject matter of the contract and shall supersede all documents and verbal consents or understandings (if any) given or made between the parties prior to the date of the contract.

(152.) None of the terms and conditions of the contract including these GTPC shall be amended or modified except by an instrument in writing or as set forth in Clause (155.).

 
Written Form

(153.) Unless mandatory Applicable Standards require otherwise, written form includes wet ink, scanned and DocuSign signatures, and fax. Email is insufficient unless expressly stated otherwise.

(154.) Any notices, declarations or directions given or made by Supplier to Cheplapharm under the contract shall be made at least in writing in order to be valid (email to suffice).

 
Updates of these GTPC

(155.) Cheplapharm shall be entitled to update these GTPC at any time.

 
Independent Contractors

(156.) The relationship hereby established between the Parties is solely that of independent contractors. Neither Party has any authority to act or make any agreements or representations on behalf of the other Party or its Affiliates. This Agreement is not intended to create, and shall not be construed as creating, between the Parties, the relationship of fiduciary, principal and agent, employer and employee, joint-venture partners, co-partners, or any other such relationship, the existence of which is expressly denied. No employee or agent engaged by either Party shall be, or shall be deemed to be, an employee or agent of the other Party and shall not be entitled to any benefits that such other Party provides to its own employees.

 
Governing Law | Venue

(157.) The contract including these GTPC and all rights arising out of or in connection therewith shall be exclusively construed by and enforced in accordance with the laws of the Federal Republic of Germany without regard to its conflict of laws principles. The U.N. Convention on Contracts for the International Sale of Goods shall not apply. 

(158.) The exclusive place of jurisdiction for all disputes arising from or in connection with the contract including these GTPC shall be Berlin, Germany. 

 
Severability

(159.) If any provision of the contract including these GTPC is held to be illegal, invalid or unenforceable, such provision shall be limited or eliminated to the minimum extent necessary so that the contract including these GTPC otherwise remains in full force and effect and shall be enforceable.

 
Waivers

(160.) Any valid waiver shall be made in writing and signed by the waiving party. Any failure or delay in exercising any right or remedy shall not prevent any future exercise of that right or remedy.

 
Publicity

(161.) Supplier must not use the name, insignia, symbol, trademark, trade name or logotype of Cheplapharm or any of its Affiliates (or any abbreviation or adaptation thereof) in any press release or other promotional material without Cheplapharm’s express prior written approval.

 
Language

(162.) In the event of a conflict or inconsistency between the English version and any other language version of these GTPC, the English version shall take precedence.

***

Back to top expand_less